Cancer Treatment: Immunotherapy Drug Nivolumab Improves Survival Rates In Patients, Study Shows

Facebook
ВКонтакте
share_fav

An immunotherapy drug has been described a potential “game changer” after a new study found that the drug improves survival in patients suffering from relapsed head and neck cancer. Patients with advance head and neck cancer have poor survival rates since the disease is very difficult to treat.

посмотреть на IB Times: World